Effects of switching from clopidogrel to prasugrel at the chronic phase after coronary stenting on antiplatelet action and vascular endothelial function: Switch-Pras study.

MLA

Masuyama, Taiki, et al. “Effects of Switching from Clopidogrel to Prasugrel at the Chronic Phase after Coronary Stenting on Antiplatelet Action and Vascular Endothelial Function: Switch-Pras Study.” Heart and Vessels, vol. 36, no. 4, Apr. 2021, pp. 442–51. EBSCOhost, https://doi.org/10.1007/s00380-020-01714-w.

APA

Masuyama, T., Sakuma, M., Waku, R., Hirose, S., Kitahara, K., Naganuma, J., Yazawa, H., Toyoda, S., Abe, S., Nakajima, T., & Inoue, T. (2021). Effects of switching from clopidogrel to prasugrel at the chronic phase after coronary stenting on antiplatelet action and vascular endothelial function: Switch-Pras study. Heart and Vessels, 36(4), 442–451. https://doi.org/10.1007/s00380-020-01714-w

Chicago

Masuyama, Taiki, Masashi Sakuma, Ryutaro Waku, Suguru Hirose, Keijiro Kitahara, Jin Naganuma, Hiroko Yazawa, et al. 2021. “Effects of Switching from Clopidogrel to Prasugrel at the Chronic Phase after Coronary Stenting on Antiplatelet Action and Vascular Endothelial Function: Switch-Pras Study.” Heart and Vessels 36 (4): 442–51. doi:10.1007/s00380-020-01714-w.